Breathe BioMedical, a Canadian medical technology company developing a breath test for breast cancer, raised the proposed deal size for its upcoming IPO on Friday. The Moncton, Canada-based company now plans to raise $13 million by offering 2.6 million shares...read more
Breathe BioMedical, a Canadian medical technology company developing a breath test for breast cancer, announced terms for its IPO on Friday. The Moncton, Canada-based company plans to raise $8 million by offering 1.6 million shares at a price range of $4 to $6....read more
Five IPOs debuted this week, and raised over $1.3 billion in proceeds. One SPAC also listed. One name that did not join the fray was aluminum company Novelis (NVL), which called off its planned $878 million IPO at the eleventh-hour. Three IPOs...read more
Breathe BioMedical, a Canadian medical technology company developing a breath test for breast cancer, filed on Friday with the SEC to raise up to $12 million in an initial public offering. The company plans to concurrently list its shares in Canada, though it...read more
Canadian diagnostics developer Breathe BioMedical increases share offering by 64% ahead of $13 million US IPO
Breathe BioMedical, a Canadian medical technology company developing a breath test for breast cancer, raised the proposed deal size for its upcoming IPO on Friday. The Moncton, Canada-based company now plans to raise $13 million by offering 2.6 million shares...read more
Canadian diagnostics developer Breathe BioMedical sets terms for $8 million US IPO
Breathe BioMedical, a Canadian medical technology company developing a breath test for breast cancer, announced terms for its IPO on Friday. The Moncton, Canada-based company plans to raise $8 million by offering 1.6 million shares at a price range of $4 to $6....read more
US IPO Weekly Recap: Healthcare software leads $1.3 billion IPO week, even as Novelis calls off IPO
Five IPOs debuted this week, and raised over $1.3 billion in proceeds. One SPAC also listed. One name that did not join the fray was aluminum company Novelis (NVL), which called off its planned $878 million IPO at the eleventh-hour. Three IPOs...read more
Canadian diagnostics developer Breathe BioMedical files for a $12 million dual listing in the US and Canada
Breathe BioMedical, a Canadian medical technology company developing a breath test for breast cancer, filed on Friday with the SEC to raise up to $12 million in an initial public offering. The company plans to concurrently list its shares in Canada, though it...read more